Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Castan

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Medecine Et Maladies Infectieuses|November 19, 2016
[Antibiotic stewardship: What's new?]B Castan, P Lesprit, S Alfandari, et al.
Medecine Et Maladies Infectieuses|August 8, 2017
[Antibiotic stewardship: A 2017 update]B Castan, P Lesprit, S Alfandari, et al.
Infectious Diseases Now|March 11, 2022
Utilization of macrolides. State of the art 2022 Spilf and GPIPJ P Stahl, B Castan, E Bonnet, et al.
Infectious Diseases Now|June 23, 2021
Anti-infectious treatment duration: The SPILF and GPIP French guidelines and recommendationsR Gauzit, B Castan, E Bonnet, et al.
Journal of Medical Virology|January 26, 2011
Influence of HCV genotype 1 subtypes on the virus response to PEG interferon alpha-2a plus ribavirin therapyF Nicot, L Alric, K Barange, et al.
Medecine Et Maladies Infectieuses|September 29, 2015
[European Antibiotic Awareness Day: What is new in France?]C Pulcini, S Alfandari, F Ballereau, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Medecine Et Maladies Infectieuses|November 19, 2016
[Antibiotic stewardship: What's new?]B Castan, P Lesprit, S Alfandari, et al.
Medecine Et Maladies Infectieuses|August 8, 2017
[Antibiotic stewardship: A 2017 update]B Castan, P Lesprit, S Alfandari, et al.
Infectious Diseases Now|March 11, 2022
Utilization of macrolides. State of the art 2022 Spilf and GPIPJ P Stahl, B Castan, E Bonnet, et al.
Infectious Diseases Now|June 23, 2021
Anti-infectious treatment duration: The SPILF and GPIP French guidelines and recommendationsR Gauzit, B Castan, E Bonnet, et al.
Journal of Medical Virology|January 26, 2011
Influence of HCV genotype 1 subtypes on the virus response to PEG interferon alpha-2a plus ribavirin therapyF Nicot, L Alric, K Barange, et al.
Medecine Et Maladies Infectieuses|September 29, 2015
[European Antibiotic Awareness Day: What is new in France?]C Pulcini, S Alfandari, F Ballereau, et al.
Pageof 2